在一名HHV8阳性、HIV阴性患者中，利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。 - Suppr

Suppr

超能文献

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.

作者信息

Law Alastair B, Ryan Gail, Lade Stephen, Prince H Miles

出版信息

Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.

DOI:10.1007/s12185-010-0497-9

PMID:20146033

Abstract

摘要

相似文献

Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient.在一名HHV8阳性、HIV阴性患者中，利妥昔单抗治疗使多中心Castleman病完全缓解后发生卡波西肉瘤。

Int J Hematol. 2010 Mar;91(2):347-8; author reply 349. doi: 10.1007/s12185-010-0497-9. Epub 2010 Feb 10.

Actas Dermosifiliogr. 2006 Jul-Aug;97(6):385-90. doi: 10.1016/s0001-7310(06)73425-1.

HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.HHV8 阳性、HIV 阴性多中心 Castleman 病：利妥昔单抗治疗的早期和持续完全缓解，无卡波西肉瘤再激活。

Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.

Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman's disease induced with anti-CD20.一名全血细胞减少的HIV阴性、HHV-8阳性的多中心Castleman病患者经抗CD20治疗后完全缓解。

Clin Transl Oncol. 2006 Jul;8(7):540-1. doi: 10.1007/s12094-006-0056-2.

Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.初治HIV感染患者中的浆细胞变异型多中心Castleman病和卡波西肉瘤

AIDS Res Hum Retroviruses. 2018 Feb;34(2):127-128. doi: 10.1089/aid.2017.0117. Epub 2018 Jan 18.

Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.在一名HIV阴性、HHV-8阳性的多中心Castleman病患者中，联合化疗免疫疗法（R-CVP）后序贯利妥昔单抗维持治疗实现完全缓解和病毒学应答。

Leuk Lymphoma. 2008 Nov;49(11):2224-6. doi: 10.1080/10428190802389835.

Rituximab therapy for HIV-associated Castleman disease.利妥昔单抗治疗HIV相关的卡波西肉瘤样血管内皮瘤病。

Blood. 2003 Oct 15;102(8):2786-8. doi: 10.1182/blood-2003-03-0951. Epub 2003 Jul 3.

Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.用甲氨蝶呤治疗的类风湿关节炎患者中，HIV阴性、卡波西肉瘤疱疹病毒相关多中心Castleman病的持久缓解。

Clin Rheumatol. 2007 Jul;26(7):1148-50. doi: 10.1007/s10067-006-0272-8. Epub 2006 Jul 6.

Discordant HHV8 detection in a young HIV-negative patient with Kaposi's sarcoma and sarcoidosis.一名年轻的HIV阴性卡波西肉瘤和结节病患者中HHV8检测结果不一致。

Clin Infect Dis. 2001 Apr 1;32(7):1100-2. doi: 10.1086/319603. Epub 2001 Mar 15.

How I treat HHV8/KSHV-related diseases in posttransplant patients.我如何治疗移植后患者的 HHV8/KSHV 相关疾病。

Blood. 2012 Nov 15;120(20):4150-9. doi: 10.1182/blood-2012-04-421412. Epub 2012 Sep 11.

引用本文的文献

Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment.

J Oncol Pract. 2018 Sep;14(9):565-568. doi: 10.1200/JOP.18.00246. Epub 2018 Jul 25.

Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.Castleman病的临床特征与预后：185例中国患者的多中心研究

Cancer Sci. 2018 Jan;109(1):199-206. doi: 10.1111/cas.13439. Epub 2017 Dec 28.

Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.硼替佐米联合来那度胺挽救治疗复发/难治性Castleman 病三例报告

Front Med. 2017 Jun;11(2):287-292. doi: 10.1007/s11684-017-0510-2. Epub 2017 Apr 3.

Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.托珠单抗单药治疗类风湿关节炎合并医源性卡波西肉瘤 1 例

Clin Drug Investig. 2014 Feb;34(2):159-61. doi: 10.1007/s40261-013-0159-9.

Multicentric Castleman's disease: a challenging diagnosis.多中心性 Castleman 病：一项具有挑战性的诊断。

Pathol Oncol Res. 2013 Jul;19(3):345-51. doi: 10.1007/s12253-013-9619-z. Epub 2013 Mar 21.

Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.用靶向病毒gpK8.1A包膜糖蛋白的重组免疫毒素选择性杀伤卡波西肉瘤相关疱疹病毒裂解感染的细胞。

MAbs. 2012 Mar-Apr;4(2):233-42. doi: 10.4161/mabs.4.2.19262. Epub 2012 Mar 1.

An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.一种针对 KSHV 的 gH 糖蛋白的免疫毒素，用于选择性杀伤感染裂解期的细胞。

Antiviral Res. 2011 Jun;90(3):143-50. doi: 10.1016/j.antiviral.2011.03.175. Epub 2011 Mar 31.

本文引用的文献

Int J Hematol. 2009 Oct;90(3):392-396. doi: 10.1007/s12185-009-0418-y. Epub 2009 Sep 12.

HIV-associated multicentric Castleman disease.人类免疫缺陷病毒相关多中心性Castleman病

Curr Opin HIV AIDS. 2009 Jan;4(1):16-21. doi: 10.1097/coh.0b013e328319bca9.

Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.HIV阳性个体中多中心性Castleman病累及的淋巴结常伴有卡波西肉瘤累及。

Am J Surg Pathol. 2008 Jul;32(7):1006-12. doi: 10.1097/PAS.0b013e318160ed97.

Brief communication: rituximab in HIV-associated multicentric Castleman disease.简短通讯：利妥昔单抗治疗HIV相关多中心Castleman病

Ann Intern Med. 2007 Dec 18;147(12):836-9. doi: 10.7326/0003-4819-147-12-200712180-00003.

Castleman disease.卡斯特曼病

Curr Opin Hematol. 2007 Jul;14(4):354-9. doi: 10.1097/MOH.0b013e328186ffab.

Actas Dermosifiliogr. 2006 Jul-Aug;97(6):385-90. doi: 10.1016/s0001-7310(06)73425-1.

Progression of classic Kaposi's sarcoma with rituximab.

J Am Acad Dermatol. 2005 Jul;53(1):155-7. doi: 10.1016/j.jaad.2004.12.048.

Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.环孢素治疗的HIV-1阴性患者发生多中心Castleman病和卡波西肉瘤：病例报告

BMC Blood Disord. 2003 Dec 11;3(1):3. doi: 10.1186/1471-2326-3-3.

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma.最低点B细胞计数与卡波西肉瘤的风险显著相关。

Int J Cancer. 2004 Jan 20;108(3):473-4. doi: 10.1002/ijc.11601.

Rituximab therapy for HIV-associated Castleman disease.利妥昔单抗治疗HIV相关的卡波西肉瘤样血管内皮瘤病。

Blood. 2003 Oct 15;102(8):2786-8. doi: 10.1182/blood-2003-03-0951. Epub 2003 Jul 3.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验